Trials / Conditions / Locally Advanced Non-Small Cell Lung Cancer

Locally Advanced Non-Small Cell Lung Cancer

25 registered clinical trials studyying Locally Advanced Non-Small Cell Lung Cancer — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NS NCT07523464	Anhui Provincial Hospital	Phase 1
Recruiting	NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer NCT07224152	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Not Yet Recruiting	Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC NCT07309952	Yang Hong	Phase 2
Recruiting	A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing NCT06066138	National Cancer Institute (NCI)	Phase 1
Recruiting	Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Adva NCT07052669	Sun Yat-sen University	Phase 3
Not Yet Recruiting	Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCL NCT06837948	Shanghai Pulmonary Hospital, Shanghai, China	Phase 2
Recruiting	RAPART in Locally Advanced Non-small Cell Lung Cancer Patients NCT07164885	Capital Medical University	N/A
Recruiting	Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunot NCT06734702	Sun Yat-sen University	Phase 3
Recruiting	Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-adv NCT06755684	Peng Zhang	Phase 2
Unknown	The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer NCT06287320	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	—
Recruiting	Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT NCT07037680	JIANYANG WANG	Phase 2
Unknown	Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy NCT05620199	The Netherlands Cancer Institute	N/A
Recruiting	Patient's Whole Process Follow-up Management(HOPE-1) NCT05339568	Qianfoshan Hospital	—
Withdrawn	Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidati NCT05481775	Sun Yat-sen University	Phase 2
Unknown	Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced NCT05111197	Institut Cancerologie de l'Ouest	Phase 3
Unknown	A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated NCT04749394	Chinese Academy of Medical Sciences	Phase 2
Completed	Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC NCT04648033	University of Oxford	Phase 1
Not Yet Recruiting	Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advance NCT04153734	Kobe Minimally Invasive Cancer Center	Phase 2
Unknown	Prevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone Propionate NCT03886441	Tongji University	Phase 2
Unknown	Sleep Apnea and Lung Cancer NCT03741647	Zagazig University	—
Completed	ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START Trial NCT01537991	Lisette Nixon	N/A
Completed	Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) NCT01059552	Fox Chase Cancer Center	Phase 1
Completed	Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With NCT00702975	Radboud University Medical Center	Phase 2
Completed	A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemot NCT03371550	Centre Antoine Lacassagne	Phase 2
Terminated	Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer NCT00614484	Loma Linda University	Phase 1 / Phase 2